Kidney Research and Clinical Practice

Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E₂ receptor EP4

Yu Ah Hong, Keum Jin Yang, So Young Jung, Yoon Kyung Chang, Cheol Whee Park, Chul Woo Yang, Suk Young Kim, Hyeon Seok Hwang

Kidney Res Clin Pract. 2017;36(2):145-158. Published online 2017 Jun 30 DOI: https://doi.org/10.23876/j.krcp.2017.36.2.145

Citations to this article as recorded by

Knockdown of SEMA7A alleviates MPP+‐induced apoptosis and inflammation in BV2 microglia via PPAR‐γ activation and MAPK inactivation

Weinan Qi, Dan Zeng, Xiaoshuan Xiong, Qun Hu

Immunity, Inflammation and Disease.2023;[Epub] CrossRef

Clinical value of thalidomide on kk-rat model through TNF-a mediated inflammation approach

Min HUANG, Jie DUAN, Bin YU, Si-lin ZHENG, Qi CHEN, Fei LIN, Nan ZENG, Bao-dong LING

Food Science and Technology.2022;[Epub] CrossRef

Evaluation of the protective effect of paricalcitol and vitamin D3at doxorubicin nephrotoxicity in rats with99mTechnetium-dimercaptosuccinic acid renal scintigraphy and biochemical methods

Fadime Demir, Mustafa Demir, Hatice Aygun

Human & Experimental Toxicology.2021; 40(2): 274. CrossRef

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of High-Dose, Short-Term Vitamin D Administration in the Prevention of Acute Kidney Injury after Cardiac Surgery

Pegah Eslami, Manouchehr Hekmat, Mahmoud Beheshti, Ramin Baghaei, Seyed Mohsen Mirhosseini, Fatemeh Pourmotahari, Seyed Ali Ziai, Mahnoosh Foroughi

Cardiorenal Medicine.2021; 11(1): 52. CrossRef

miRNA-20a suppressed lipopolysaccharide‐induced HK‐2 cells injury via NFκB and ERK1/2 signaling by targeting CXCL12

Li zhang, Shuai He, Yun Wang, Xinyu Zhu, Wenying Shao, Qian Xu, Zhangke Cui

Molecular Immunology.2020; 118: 117. CrossRef

Protective Role of Vitamin D in Renal Tubulopathies

Guido Gembillo, Valeria Cernaro, Rossella Siligato, Francesco Curreri, Antonino Catalano, Domenico Santoro

Metabolites.2020; 10(3): 115. CrossRef

Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling

Dangfeng Zhang, Lin Qiao, Ting Fu

Biomedicine & Pharmacotherapy.2020; 125: 109528. CrossRef

LncRNA TapSAKI promotes inflammation injury in HK-2 cells and urine derived sepsis-induced kidney injury

Jun Shen, Li Liu, Facai Zhang, Jiang Gu, Guanghui Pan

Journal of Pharmacy and Pharmacology.2019; 71(5): 839. CrossRef

Co-targeting of endothelin-A and vitamin D receptors: a novel strategy to ameliorate cisplatin-induced nephrotoxicity

Lobna M. Abdel Moneim, Maged W. Helmy, Hanan S. El-Abhar

Pharmacological Reports.2019; 71(5): 917. CrossRef

Prostaglandins in the pathogenesis of kidney diseases

Yuanyuan Li, Weiwei Xia, Fei Zhao, Zhaoying Wen, Aihua Zhang, Songming Huang, Zhanjun Jia, Yue Zhang

Oncotarget.2018; 9(41): 26586. CrossRef

Anti-inflammatory and anti-apoptotic effects of paricalcitol in lipopolysaccharide-induced renal proximal tubular cell injury

Soo Wan Kim

Kidney Research and Clinical Practice.2017; 36(2): 109. CrossRef